Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
111,633,839
-
Total 13F shares
-
85,201,916
-
Share change
-
+2,195,317
-
Total reported value
-
$2,616,570,243
-
Put/Call ratio
-
72%
-
Price per share
-
$30.71
-
Number of holders
-
203
-
Value change
-
+$66,075,676
-
Number of buys
-
100
-
Number of sells
-
101
Institutional Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q2 2022
As of 30 Jun 2022,
Evolent Health, Inc. - Class A Common Stock (EVH) was held by
203 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,201,916 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Engaged Capital LLC, JPMORGAN CHASE & CO, Granahan Investment Management, LLC, CREDIT SUISSE AG/, Rock Springs Capital Management LP, DIMENSIONAL FUND ADVISORS LP, LOOMIS SAYLES & CO L P, and FRED ALGER MANAGEMENT, LLC.
This page lists
204
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.